HomeCompareOTSKF vs ARCC

OTSKF vs ARCC: Dividend Comparison 2026

OTSKF yields 1.29% · ARCC yields 10.65%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OTSKF wins by $6.0K in total portfolio value· pulled ahead in Year 7
10 years
OTSKF
OTSKF
● Live price
1.29%
Share price
$70.34
Annual div
$0.91
5Y div CAGR
30.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$2,626.27
Full OTSKF calculator →
ARCC
Ares Capital Corporation
● Live price
10.65%
Share price
$18.02
Annual div
$1.92
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.5K
Annual income
$1.14
Full ARCC calculator →

Portfolio growth — OTSKF vs ARCC

📍 OTSKF pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOTSKFARCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OTSKF + ARCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OTSKF pays
ARCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OTSKF
Annual income on $10K today (after 15% tax)
$109.97/yr
After 10yr DRIP, annual income (after tax)
$2,232.33/yr
ARCC
Annual income on $10K today (after 15% tax)
$905.66/yr
After 10yr DRIP, annual income (after tax)
$0.97/yr
At 15% tax rate, OTSKF beats the other by $2,231.36/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OTSKF + ARCC for your $10,000?

OTSKF: 50%ARCC: 50%
100% ARCC50/50100% OTSKF
Portfolio after 10yr
$27.5K
Annual income
$1,313.70/yr
Blended yield
4.78%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ARCC right now

OTSKF
No analyst data
Altman Z
5.2
Piotroski
6/9
ARCC
Analyst Ratings
24
Buy
7
Hold
Consensus: Buy
Price Target
$21.88
+21.4% upside vs current
Range: $21.00 — $23.00
Altman Z
0.8
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OTSKF buys
0
ARCC buys
0
No recent congressional trades found for OTSKF or ARCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOTSKFARCC
Forward yield1.29%10.65%
Annual dividend / share$0.91$1.92
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR30.5%-50%
Portfolio after 10y$30.5K$24.5K
Annual income after 10y$2,626.27$1.14
Total dividends collected$9.2K$1.1K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: OTSKF vs ARCC ($10,000, DRIP)

YearOTSKF PortfolioOTSKF Income/yrARCC PortfolioARCC Income/yrGap
1$10,869$168.83$11,373$532.74$504.00ARCC
2$11,853$223.80$12,608$279.46$755.00ARCC
3$12,981$297.68$13,809$142.90$828.00ARCC
4$14,287$397.59$15,042$72.20$755.00ARCC
5$15,821$533.70$16,341$36.27$520.00ARCC
6$17,649$720.80$17,732$18.18$83.00ARCC
7← crossover$19,865$980.70$19,231$9.10+$634.00OTSKF
8$22,602$1,346.27$20,851$4.55+$1.8KOTSKF
9$26,052$1,868.16$22,605$2.28+$3.4KOTSKF
10$30,502$2,626.27$24,504$1.14+$6.0KOTSKF

OTSKF vs ARCC: Complete Analysis 2026

OTSKFStock

Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses. It also provides BODYMAINTÉ Jelly, a conditioning food product; BODYMAINTÉ Drink, a conditioning beverage; EQUELLE and EQUELLE Gelée, which supports women's health and beauty; POCARI SWEAT, a drink; Calorie Mate, a nutritional food; and OS-1, an oral rehydration solution. In addition, the company offers soft drinks, food products, and wines; clinical testing and medical equipment; cosmetics; warehousing and transport services; chemical products; travel agency services; analysis and measurement equipment; pharmaceutical intermediates; testing equipment, such as vehicle headlight testers; synthetic resin molded products; venture capital services; paper products; artificial turf; ceramic boards, ceramic board masterpiece arts, ceramic walls, reliefs, terracotta, OT ceramics, and ceramic portraits and sign boards; functional films; IT solution services; insecticides and toiletry products; and flaky titanate and special compounds. Further, it provides infusion and clinical nutrition products; Xenotransplantation products; hydrazine; plant-based food products, including cheese alternatives, dressings, and desserts; stable isotopes; software and services to enhance management of mental healthcare systems; products for urinary tract health; potassium titanate; bio-pesticides; functional and dietetic foods; spring and mineral water; industrial chemicals; polyolefin foams; anticancer drugs; and adhesive tapes. Additionally, the company operates a hotel. Otsuka Holdings Co., Ltd. was founded in 1921 and is based in Tokyo, Japan.

Full OTSKF Calculator →

ARCCBDC

Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.

Full ARCC Calculator →
📬

Get this OTSKF vs ARCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OTSKF vs SCHDOTSKF vs JEPIOTSKF vs OOTSKF vs KOOTSKF vs MAINOTSKF vs HTGCOTSKF vs GBDCOTSKF vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.